1-(3-Chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-N-cyclohexyl-N-methylpiperidine-4-carboxamide

Catalog No. :
ACUEUW171
CAS No. :
439108-67-5
Molecular Formula :
C23H27ClN2O3
Molecular Weight :
414.93

IUPAC Name:1-(3-chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-N-cyclohexyl-N-methylpiperidine-4-carboxamide

1-(3-Chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-N-cyclohexyl-N-methylpiperidine-4-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$286.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-N-cyclohexyl-N-methylpiperidine-4-carboxamide
IUPAC Name1-(3-chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-N-cyclohexyl-N-methylpiperidine-4-carboxamide
MDL No.MFCD04125443
Molecular FormulaC23H27ClN2O3
Molecular Weight414.93
SMILESO=C(C1CCN(C(C2=O)=C(Cl)C(C3=C2C=CC=C3)=O)CC1)N(C4CCCCC4)C
InChI KeyGTOMKZSMLPJURD-UHFFFAOYSA-N
Synonym1-(3-CHLORO-1,4-DIOXO-1,4-DIHYDRO-2-NAPHTHALENYL)-N-CYCLOHEXYL-N-METHYL-4-PIPERIDINECARBOXAMIDE;1-(3-chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-N-cyclohexyl-N-methylpiperidine-4-carboxamide;4-Piperidinecarboxamide, 1-(3-chloro-1,4-dihydro-1,4-dioxo-2-naphthalenyl)-N-cyclohexyl-N-methyl-
CAS No.439108-67-5

Synthetic Route by SureRoute

1. ACUEUW171 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUEUW171 route product structure diagram
    ACUEUW171439108-67-5
Inquiry

2. ACUEUW171 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUEUW171 route product structure diagram
    ACUEUW171439108-67-5
Inquiry

Comments (0)